, Tracking Stock Market Picks
Enter Symbol:
Alexion Pharmaceuticals, Inc. (ALXN) [hlAlert]

up 10.36 %

Alexion Pharmaceuticals, Inc. (ALXN) rated Buy with price target $200 by Brean Capital

Posted on: Thursday,  Jan 30, 2014  2:25 PM ET by Brean Capital

Brean Capital rated Buy Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) on 01/30/2014, when the stock price was $162.93. Since
then, Alexion Pharmaceuticals, Inc. has gained 10.37% as of 12/11/2015's recent price of $179.82.
If you would have followed this Brean Capital's recommendation on ALXN, you would have gained 10.36% of your investment in 680 days.

Alexion Pharmaceuticals develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans. The company's lead product candidates are genetically altered antibodies that target specific diseases which arise when the human immune system induces undesired inflammation in the human body. These candidates are designed to block components of the human immune system which cause undesired inflammation while allowing beneficial components of the immune system to remain functional.

Brean Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/30/2014 2:25 PM Buy
162.93 200.00
as of 10/17/2014
1 Week down  -1.81 %
1 Month up  1.99 %
3 Months up  6.24 %
1 YTD up  1.11 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy